| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.
1 Section on Oxidative Stress Tissue Injury, Lab. Physiol. Studies, National Institutes of Health/NIAAA, Bethesda, Maryland, United States
2 Surgery, UMDNJ-New Jersey Medical School,, Newark, New Jersey, United States
3 Department of Intensive Care Medicine, University Hospital, 1011 Lausanne, Lausanne, VD, Switzerland
4 Howard L. Hunter Chemistry Laboratory, Clemson University, Clemson, South Carolina, United States
5 Physiology, New York Medical College, Valhalla, New York, United States
6 Physiology, New York Medical College, Valhalla, United States
7 Univ. of Washington, United States
8 Department of Pediatrics, Lipid Research Unit, Johns Hopkins University, Baltimore, Maryland, United States
* To whom correspondence should be addressed. E-mail: pacher{at}mail.nih.gov.
Targeting cannabinoid-2 (CB2) receptors with selective agonists may represent a novel therapeutic avenue in various inflammatory diseases, but the mechanisms by which CB2 activation exerts its anti-inflammatory effects and the cellular targets are elusive. Here we investigated the effects of CB2 receptor activation on TNF-
-induced signal transduction in human coronary artery endothelial cells (HCAECs) in vitro and on endotoxin-induced vascular inflammatory response in vivo. TNF- induced NF-
B and RhoA activation, up-regulation of adhesion molecules ICAM-1 and VCAM-1, increased expression of monocyte chemoattractant protein, enhanced transendothelial migration of monocytes, and augmented monocyte-endothelial adhesion. Remarkably, all the above mentioned effects of TNF- were attenuated by CB2 agonists. CB2 agonists also decreased the TNF-- and/or endotoxin-induced ICAM-1 and VCAM-1 expression in isolated aortas, and adhesion of monocytes to aortic vascular endothelium. CB1 and CB2 receptors were detectable in human coronary artery endothelial cells by western blotting, RT-PCR, real-time PCR and immunofluorescence staining. Since the above mentioned TNF--induced phenotypic changes are critical in the initiation and progression of atherosclerosis and restenosis our findings suggest that targeting CB2 receptors on endothelial cells may offer a novel approach in the treatment of these pathologies.
This article has been cited by other articles:
|
|
 |
|
  M. Iribarne, V. Torbidoni, K. Julian, J. P. Prestifilippo, D. Sinha, V. Rettori, A. Berra, and A. M. Suburo Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4535 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, P. Mukhopadhyay, R. Mohanraj, G. Godlewski, S. Batkai, and G. Kunos Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations Hypertension, October 1, 2008; 52(4): 601 - 607. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher and B. Gao Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G850 - G854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montecucco, F. Burger, F. Mach, and S. Steffens CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1145 - H1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pacher and Z. Ungvari Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1133 - H1134. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
